Lapatinib May Boost Effectiveness of Drugs That Destroy Cancer Proteins by Blocking Resistance
August 31, 2022 James S. Duncan, PhD, associate professor in the Cancer Signaling and Epigenetics research program at Fox Chase.
Source: pressreleasepoint.com